WO2003046152A3 - Molecules for disease detection and treatment - Google Patents

Molecules for disease detection and treatment Download PDF

Info

Publication number
WO2003046152A3
WO2003046152A3 PCT/US2002/038446 US0238446W WO03046152A3 WO 2003046152 A3 WO2003046152 A3 WO 2003046152A3 US 0238446 W US0238446 W US 0238446W WO 03046152 A3 WO03046152 A3 WO 03046152A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
molecules
mddt
disease detection
diseasedetection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2002/038446
Other languages
French (fr)
Other versions
WO2003046152A2 (en
Inventor
Y Tom Tang
Narinder K Chawla
Dyung Aina M Lu
Farrah A Khan
Ameena R Gandhi
Anita Swarnakar
Yalda Azimzai
Joseph P Marquis
William W Sprague
Brooke M Emerling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Priority to EP02794113A priority Critical patent/EP1487989A2/en
Priority to AU2002359567A priority patent/AU2002359567A1/en
Publication of WO2003046152A2 publication Critical patent/WO2003046152A2/en
Anticipated expiration legal-status Critical
Publication of WO2003046152A3 publication Critical patent/WO2003046152A3/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Various embodiments of the invention provide human molecules for diseasedetection and treatment (MDDT) and polynucleotides which identify and encode MDDT. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of MDDT.
PCT/US2002/038446 2001-11-28 2002-11-25 Molecules for disease detection and treatment Ceased WO2003046152A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP02794113A EP1487989A2 (en) 2001-11-28 2002-11-25 Molecules for disease detection and treatment
AU2002359567A AU2002359567A1 (en) 2001-11-28 2002-11-25 Molecules for disease detection and treatment

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US33418201P 2001-11-28 2001-11-28
US60/334,182 2001-11-28
US34205201P 2001-12-18 2001-12-18
US60/342,052 2001-12-18
US35041002P 2002-01-18 2002-01-18
US60/350,410 2002-01-18
US35328402P 2002-02-01 2002-02-01
US60/353,284 2002-02-01
US36364902P 2002-03-08 2002-03-08
US60/363,649 2002-03-08

Publications (2)

Publication Number Publication Date
WO2003046152A2 WO2003046152A2 (en) 2003-06-05
WO2003046152A3 true WO2003046152A3 (en) 2004-09-30

Family

ID=27541121

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/038446 Ceased WO2003046152A2 (en) 2001-11-28 2002-11-25 Molecules for disease detection and treatment

Country Status (3)

Country Link
EP (1) EP1487989A2 (en)
AU (1) AU2002359567A1 (en)
WO (1) WO2003046152A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
EP2944651B1 (en) 2007-10-02 2018-01-31 Universität zu Köln Novel marker genes for regulatory t cells from human blood
EP2842566A1 (en) * 2013-09-03 2015-03-04 Centre National De La Recherche Scientifique Use of arpin a new inhibitor of the arp2/3 complex for the diagnosis and treatment of diseases

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001057276A2 (en) * 2000-02-04 2001-08-09 Aeomica, Inc. Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human bone marrow

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001057276A2 (en) * 2000-02-04 2001-08-09 Aeomica, Inc. Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human bone marrow

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE GENEBANK [online] 21 December 1999 (1999-12-21), XP002978404, accession no. EMBL Database accession no. (AC006042) *

Also Published As

Publication number Publication date
EP1487989A2 (en) 2004-12-22
AU2002359567A1 (en) 2003-06-10
AU2002359567A8 (en) 2003-06-10
WO2003046152A2 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
WO2003052075A3 (en) Enzymes
WO2002063005A3 (en) Lipid-associated molecules
WO2003016497A3 (en) Molecules for disease detection and treatment
WO2003042357A3 (en) Enzymes
WO2002097060A3 (en) Carbohydrate-associated proteins
WO2004044165A3 (en) Lipid-associated proteins
WO2003031568A8 (en) Intracellular signaling molecules
WO2004053068A3 (en) Protein modification and maintenance molecules
WO2003052049A3 (en) Molecules for disease detection and treatment
WO2004009797A3 (en) Protein modification and maintenance molecules
WO2003063688A3 (en) Protein modification and maintenance molecules
WO2002101008A3 (en) Intracellular signaling molecules
WO2002060942A3 (en) Protein modification and maintenance molecules
WO2003031595A3 (en) Molecules for disease detection and treatment
WO2003031939A3 (en) Protein modification and maintenance molecules
WO2002066646A3 (en) Neurotransmission-associated proteins
WO2003083084A3 (en) Protein modification and maintenance molecules
WO2003046152A3 (en) Molecules for disease detection and treatment
WO2002078420A3 (en) Molecules for disease detection and treatment
WO2003100016A3 (en) Protein modification and maintenance molecules
WO2003010329A3 (en) Nucleic acid-associated proteins
WO2002046413A3 (en) Molecules for disease detection and treatment
WO2003025150A3 (en) Lipid-associated molecules
WO2002064792A3 (en) Molecules for disease detection and treatment
WO2003093427A3 (en) Molecules for disease detection and treatment

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2002794113

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002794113

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2002794113

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP